-
Mashup Score: 60
By M Shahzad Rauf, Irfan Maghfoor & 6 more. Our study suggests that in patients with primary refractory DLBCL without initial progressive disease after frontline R-CHOP, the depth of response to SC before HDC–ASCT is predictive of relapse.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3IACH News - 26 day(s) ago
IACH News Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access.
Source: clinical-hematology.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 88Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations | Published in Clinical Hematology International - 30 day(s) ago
By Katie Gatwood, Zahra Mahmoudjafari & 6 more. This review provides a summary of currently published experiences, as well as expert opinion regarding implementation of an outpatient CAR-T program.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38Transfusion Support in Hematopoietic Stem Cell Transplantation: A Contemporary Narrative Review | Published in Clinical Hematology International - 1 month(s) ago
By Brian D. Adkins, Jeremy W. Jacobs & 3 more. Herein, we detail contemporary blood transfusion and transfusion medicine practices for patients undergoing HSCT.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 81Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations | Published in Clinical Hematology International - 1 month(s) ago
By Katie Gatwood, Zahra Mahmoudjafari & 6 more. This review provides a summary of currently published experiences, as well as expert opinion regarding implementation of an outpatient CAR-T program.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 77Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations | Published in Clinical Hematology International - 1 month(s) ago
By Katie Gatwood, Zahra Mahmoudjafari & 6 more. This review provides a summary of currently published experiences, as well as expert opinion regarding implementation of an outpatient CAR-T program.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Abstract Submission - 1 month(s) ago
Abstract Submission Deadline: April 9, 2024 Submit your abstract Abstracts for the Congress: Participants who would like to actively participate in the congress are requested to submit an abstract for review by the Scientific Committee. The Committee reserves the right to: 1) select the abstracts relevant to the sessions; 2) decide on the final form
Source: comylive.cme-congresses.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Abstract Submission - 1 month(s) ago
Abstract Submission Deadline: April 9, 2024 Submit your abstract Abstracts for the Congress: Participants who would like to actively participate in the congress are requested to submit an abstract for review by the Scientific Committee. The Committee reserves the right to: 1) select the abstracts relevant to the sessions; 2) decide on the final form
Source: comylive.cme-congresses.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 58
By Jana Sawyer, Taylor Elliott & 4 more. The acute toxicities that occur from conditioning chemotherapy can impact the peri-transplant period and have substantial implications on patients’ tolerability and outcomes, irrespective of the treatment of their disease.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23
By Tristan Knight E, Olalekan Oluwole & 1 more. We have therefore developed a relevant summary of the currently available literature pertaining to the use of CD19-directed CAR-T cell therapies in pediatric patients.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
«Outcomes of Autologous SCT in patients with primary refractory DLBCL who demonstrate chemosensitivity to salvage chemotherapy». An important study at the era of CAR-T cells - Published in Clin Hematol Int, the official journal of @TheIACH https://t.co/sABvd5S2T7